Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Lipids in Health and Disease|December 7, 2011
Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's diseasePaul L Wood, Tara Smith, Nina Lane, et al.Brain Research|October 10, 2006
Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzinePaul L Wood, M Amin Khan, Joseph R Moskal, et al.Lipids in Health and Disease|October 20, 2011
In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursorPaul L Wood, M Amin Khan, Tara Smith, et al.Current Neuropharmacology|March 22, 2016
The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting AntidepressantJoseph R Moskal, Jeffrey S Burgdorf, Patric K Stanton, et al.Journal of Neurochemistry|August 4, 2019
NYX-2925 induces metabotropic N-methyl-d-aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptorM Scott Bowers, Luisa P Cacheaux, Srishti U Sahu, et al.The Journal of Pharmacology and Experimental Therapeutics|July 11, 2018
NYX-2925 Is a Novel N-Methyl-d-Aspartate Receptor Modulator that Induces Rapid and Long-Lasting Analgesia in Rat Models of Neuropathic PainNayereh Ghoreishi-Haack, Jessica M Priebe, Jacqueline D Aguado, et al.The International Journal of Neuropsychopharmacology|November 4, 2017
NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and MemoryM Amin Khan, David R Houck, Amanda L Gross, et al.Sleep|September 11, 2019
NMDAR activation regulates the daily rhythms of sleep and moodJeffrey S Burgdorf, Martha H Vitaterna, Christopher J Olker, et al.Pageof 2